Metabolic Features of Assigned Female at Birth Transgender People on Gender-Affirming Hormone Therapy: A Meta-analysis
Transgender Health · 01.12.2024 · 9 (6) · 466-483
DOI: 10.1089/trgh.2023.0040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transgender Health, online erschienen am 16.12.2024. Verfasst von Daniele Tienforti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Andrology Unit, Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
There is a paucity of data on the safety and efficacy of long-term testosterone (T)-based gender-affirming hormone therapy (GAHT) on anthropometric parameters, body composition, and glycolipid metabolism in assigned female at birth (AFAB) persons. The purpose of this study was to provide an updated meta-analysis on this topic.
Methods
We searched PubMed, Scopus, and Cochrane Library for relevant studies. Pre-/post-therapy changes in body mass index (BMI), waist-to-hip ratio (WHR), body composition, lipid glycemic/insulinemic profiles were combined as mean differences (MD) with 95% confidence interval (CI), using random-effect models.
Results
Thirty-nine studies ( N =1949) were analyzed. At pooled estimates, GAHT was associated with significant decrease in fat mass (MD: −1.29 kg; 95% CI: −2.52 to −0.05; p =0.04) and increase in lean mass (4.12 kg; 95% CI: 3.07–5.16; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Andrology Unit, Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
- Epidemiology Division, Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
- Andrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.
- Neuroendocrinology and Metabolic Diseases, IRCCS Neuromed, Pozzilli, Italy.
ORCID-Profile: Daniele Tienforti
Zitieren
APA
Tienforti, D., Castellini, C., Di Giulio, F., Spagnolo, L., Muselli, M., Fisher, A. D., Vignozzi, L., Baroni, M. G., & Barbonetti, A. (2024). Metabolic Features of Assigned Female at Birth Transgender People on Gender-Affirming Hormone Therapy: A Meta-analysis. Transgender Health, 9(6), 466-483. https://doi.org/10.1089/trgh.2023.0040
Vancouver
Tienforti D, Castellini C, Di Giulio F, Spagnolo L, Muselli M, Fisher AD, et al. Metabolic Features of Assigned Female at Birth Transgender People on Gender-Affirming Hormone Therapy: A Meta-analysis. Transgender Health. 2024;9(6):466-483. doi:10.1089/trgh.2023.0040
BibTeX
@article{Tienforti2024,
author = {Tienforti, Daniele and Castellini, Chiara and Di Giulio, Francesca and Spagnolo, Luca and Muselli, Mario and Fisher, Alessandra D and Vignozzi, Linda and Baroni, Marco Giorgio and Barbonetti, Arcangelo},
title = {Metabolic Features of Assigned Female at Birth Transgender People on Gender-Affirming Hormone Therapy: A Meta-analysis},
journal = {Transgender Health},
year = {2024},
volume = {9},
number = {6},
pages = {466--483},
doi = {10.1089/trgh.2023.0040}
}
EUVIMED